Clover Health Hits 52-Week High: Insiders Cashing In
On Thursday, Clover Health Investments Corp (Symbol: CLOV) reached a new 52-week high of $4.71 per share. This notable rise of 672.13% translates to an increase of $4.10 from its 52-week low of $0.61, recorded on April 22, 2024. Investors who bought CLOV stock in the last year now enjoy unrealized gains, including those within the company.
In recent months, insiders have been actively purchasing shares, and these investments are proving to be quite profitable. The table below outlines two significant insider purchases in the past six months.
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 05/17/2024 | Anna U. Loengard | Director | 27,085 | $0.95 | $25,671.90 |
| 06/17/2024 | Vivek Garipalli | Director | 877,567 | $1.14 | $1,000,426.38 |
| 08/09/2024 | Vivek Garipalli | Director | 531,700 | $1.88 | $999,596.00 |
The chart below illustrates CLOV’s trading performance over the past year, including the 50-day and 200-day moving averages.
As of Thursday afternoon, CLOV shares are trading at $4.43, just below the latest 52-week high.
Discover Ten Bargains You Can Buy Cheaper Than The Insiders Did »
Also see:
• CMU Historical Stock Prices
• Funds Holding BKYI
• WDC Insider Buying
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
